Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

CABG again outshines stenting for some patients with coronary artery blockage.

Mitka M.

JAMA. 2013 Jan 2;309(1):17-8. doi: 10.1001/jama.2012.97092. No abstract available.

PMID:
23280199
2.
3.

Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials.

Verma S, Farkouh ME, Yanagawa B, Fitchett DH, Ahsan MR, Ruel M, Sud S, Gupta M, Singh S, Gupta N, Cheema AN, Leiter LA, Fedak PW, Teoh H, Latter DA, Fuster V, Friedrich JO.

Lancet Diabetes Endocrinol. 2013 Dec;1(4):317-28. doi: 10.1016/S2213-8587(13)70089-5. Epub 2013 Sep 13.

PMID:
24622417
4.

Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?

Bangalore S, Toklu B, Feit F.

Circ Cardiovasc Interv. 2014 Aug;7(4):518-25. doi: 10.1161/CIRCINTERVENTIONS.114.001346. Epub 2014 Jun 17.

5.

[Left main coronary stenting is safe and effective and is a valuable alternative to coronary artery bypass graft surgery].

Sheiban I, Zoccai GB, Moretti C.

G Ital Cardiol (Rome). 2009 Feb;10(2):113-7; discussion 117. Italian. No abstract available.

PMID:
19348149
6.

Coronary artery bypass graft surgery remains the standard of care for patients with diabetes.

Moss E, Alam M, Ballantyne CM, Puskas JD.

Semin Thorac Cardiovasc Surg. 2013 Summer;25(2):97-9. doi: 10.1053/j.semtcvs.2013.07.007. Review.

PMID:
24216525
7.
8.

The FREEDOM trial: a definitive answer to coronary artery bypass grafting or stents in patients with diabetes and multivessel coronary artery disease.

Taggart DP.

Eur J Cardiothorac Surg. 2013 Dec;44(6):978-9. doi: 10.1093/ejcts/ezt450. Epub 2013 Sep 18. No abstract available.

PMID:
24047712
9.

Are drug-eluting stents superior to bare metal stents when compared to coronary artery bypass surgery? Show me the data.

Rodriguez AE.

Cardiovasc Revasc Med. 2013 Mar-Apr;14(2):90-2. doi: 10.1016/j.carrev.2012.11.002. Epub 2013 Jan 2.

PMID:
23290662
10.

One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.

Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E.

J Thorac Cardiovasc Surg. 2005 Aug;130(2):512-9.

11.

The FREEDOM trial: in appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI.

Aggarwal B, Goel SS, Sabik JF, Shishehbor MH.

Cleve Clin J Med. 2013 Aug;80(8):515-23. doi: 10.3949/ccjm.80a.13030.

PMID:
23908108
12.

[Meta-analysis of long-term outcomes of percutaneous coronary intervention or coronary artery bypass graft surgery in coronary artery disease patients with multi-vessel and/or left main stem disease].

Sun T, Wan Y, Liu Z, Zhang S, Guan F, Yao R, Zhang L, Li L, Zhang J, Kan Q.

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Aug;42(8):693-8. Chinese.

PMID:
25388345
13.

Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease.

Rodriguez AE, Fernandez-Pereira C, Mieres J.

JAMA Intern Med. 2014 Jun;174(6):1007. doi: 10.1001/jamainternmed.2014.776. No abstract available.

PMID:
24887763
14.

Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease.

Takagi H, Umemoto T; ALICE Group.

JAMA Intern Med. 2014 Jun;174(6):1006-7. doi: 10.1001/jamainternmed.2014.773. No abstract available.

PMID:
24887761
15.

Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes.

Fanari Z, Weiss SA, Zhang W, Sonnad SS, Weintraub WS.

Interact Cardiovasc Thorac Surg. 2014 Dec;19(6):1002-7. doi: 10.1093/icvts/ivu291. Epub 2014 Sep 3. Review.

PMID:
25185569
16.

Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease--reply.

Sipahi I.

JAMA Intern Med. 2014 Jun;174(6):1007-8. doi: 10.1001/jamainternmed.2014.762. No abstract available.

PMID:
24887764
17.

ACP Journal Club. Review: CABG reduces long-term mortality and morbidity more than PCI in multivessel coronary disease.

Harskamp RE, Newby LK.

Ann Intern Med. 2014 Apr 15;160(8):JC9. doi: 10.7326/0003-4819-160-8-201404150-02009. No abstract available.

PMID:
24733226
18.

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.

Cohen DJ, Osnabrugge RL, Magnuson EA, Wang K, Li H, Chinnakondepalli K, Pinto D, Abdallah MS, Vilain KA, Morice MC, Dawkins KD, Kappetein AP, Mohr FW, Serruys PW; SYNTAX Trial Investigators.

Circulation. 2014 Sep 30;130(14):1146-57. doi: 10.1161/CIRCULATIONAHA.114.009985. Epub 2014 Aug 1.

19.

Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.

Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW.

Circulation. 2008 Sep 9;118(11):1146-54. doi: 10.1161/CIRCULATIONAHA.107.752147. Epub 2008 Aug 25.

20.

Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.

Kappetein AP, Head SJ, Morice MC, Banning AP, Serruys PW, Mohr FW, Dawkins KD, Mack MJ; SYNTAX Investigators.

Eur J Cardiothorac Surg. 2013 May;43(5):1006-13. doi: 10.1093/ejcts/ezt017. Epub 2013 Feb 14.

PMID:
23413014

Supplemental Content

Support Center